Abbott Diagnostika GmbH & Co. KG
New automated ELISA reduces detection time of HIV-specific antibodies
Published in AIDS Weekly and Law, March 18th, 2004
According to recent research published in the Journal of Clinical Microbiology, "A collaborative multicenter study was conducted to evaluate the sensitivity, specificity, and precision of a three-step, fully automated, qualitative microparticle-based enzyme-linked immunoassay (AxSYM HIV Ag/Ab Combo; Abbott Laboratories), designed to simultaneously detect antibodies against human immunodeficiency virus type 1 (HIV-1) and/or type 2 (HIV-2), and HIV p24 antigen. A significant reduction in the HIV seroconversion...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly and Law
Source: AIDS Weekly and Law (2004-03-18)
More Articles from AIDS Weekly and Law
- Adventrx Pharmaceuticals, Inc.
Cancer center receives grant for HIV/AIDS vaccine therapy - Medical Research Council Laboratories, Banjul
Cellular immunity similar for asymptomatic HIV-1 and -2-infected patients - United Nations
AIDS threat growing throughout Europe - World AIDS Foundation
Civil strife in Haiti could derail progress on HIV transmission rates - Bayer Pharmaceutical Corp.
Tat-binding surface of CBP KIX domain identified - Bionor A/S
Magnetic particle-based HIV confirmatory immunoassay suitable for use - More from this issue of AIDS Weekly and Law
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
